These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 17589952

  • 1. Prognostic value of DNA alterations on chromosome 17p13.2 for intrahepatic cholangiocarcinoma.
    Chuensumran U, Wongkham S, Pairojkul C, Chauin S, Petmitr S.
    World J Gastroenterol; 2007 Jun 07; 13(21):2986-91. PubMed ID: 17589952
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Histological type of intrahepatic cholangiocarcinoma differentiated by genetic alteration from AP-PCR fingerprint.
    Chuensumran U, Saelee P, Wongkham S, Pairojkul C, Chauin S, Petmitr S.
    Asian Pac J Cancer Prev; 2011 Jun 07; 12(6):1377-80. PubMed ID: 22126467
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Role of eIF3C Overexpression in Predicting Prognosis of Intrahepatic Cholangiocarcinoma.
    Xu YP, Dong ZN, Zhou YQ, Zhao YJ, Zhao Y, Wang F, Huang XY, Guo CY.
    Dig Dis Sci; 2022 Feb 07; 67(2):559-568. PubMed ID: 33576946
    [Abstract] [Full Text] [Related]

  • 14. Identification of a novel microRNA signature associated with intrahepatic cholangiocarcinoma (ICC) patient prognosis.
    Zhang MY, Li SH, Huang GL, Lin GH, Shuang ZY, Lao XM, Xu L, Lin XJ, Wang HY, Li SP.
    BMC Cancer; 2015 Feb 18; 15():64. PubMed ID: 25880914
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Osteopontin promoter polymorphisms at locus -443 are associated with metastasis and poor prognosis of human intrahepatic cholangiocarcinoma in Chinese population.
    Zhao XQ, Ma HX, Su MS, He L.
    Int J Clin Exp Pathol; 2014 Feb 18; 7(10):6914-21. PubMed ID: 25400775
    [Abstract] [Full Text] [Related]

  • 18. Decreased expression of HDAC8 indicates poor prognosis in patients with intrahepatic cholangiocarcinoma.
    Zhu YJ, Xu Q, Shao MY, Cao XY, Wu ZR, Chen YW, Bu H, Shi YJ.
    Hepatobiliary Pancreat Dis Int; 2019 Oct 18; 18(5):464-470. PubMed ID: 31402267
    [Abstract] [Full Text] [Related]

  • 19. The clinical characteristics and prognostic factors of combined Hepatocellular Carcinoma and Cholangiocarcinoma, Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma after Surgical Resection: A propensity score matching analysis.
    Tang Y, Wang L, Teng F, Zhang T, Zhao Y, Chen Z.
    Int J Med Sci; 2021 Oct 18; 18(1):187-198. PubMed ID: 33390787
    [Abstract] [Full Text] [Related]

  • 20. [Relationship between genetic alterations and clinicopathological features in intrahepatic cholangiocarcinoma].
    Cong W, Finkelstein SD, Wu M.
    Zhonghua Bing Li Xue Za Zhi; 2001 Jun 18; 30(3):183-7. PubMed ID: 11866974
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.